Tottenham defender Micky van de Ven is reportedly a January target for Real Madrid following a series of injuries to the Spanish club's defensive players.

StockNews.com started coverage on shares of Vanda Pharmaceuticals (NASDAQ:VNDA – Free Report) in a report released on Friday. The firm issued a hold rating on the biopharmaceutical company’s stock.

In addition to the mule slippers, the edition also includes slides. Some of these designs include pocket pouches on the top.

The year 2024 has been a mixed ride for the biotech industry. It started on a positive note, attracting investors’ attention in areas with great commercial potential, like obesity, immunology and gene ...

StockNews.com started coverage on shares of Vanda Pharmaceuticals (NASDAQ:VNDA – Get Free Report) in a report released on ...

Vanda Pharmaceuticals reported net product sales of approximately $50.5 million in the third quarter of 2024, representing a 6% quarter-over-quarter and 10% year-over-year increase. This performance, ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

African lioness Yuna was taken to its lion rescue centre in August, while the four others - Rori, Vanda, Amani and Lira - will join her in early 2025. Rori, the male lion, is temporarily living in ...